---
title: How I manage pregnant patients who are alloimmunized to RBC antigens
date: '2024-05-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38743880/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240515180747&v=2.18.0.post9+e462414
source: Blood
description: Hemolytic disease of the fetus and newborn (HDFN) remains an important
  cause of perinatal morbidity and mortality. HDFN is caused by maternal alloimmunization
  to red blood cell (RBC) antigens. This article describes and highlights issues in
  the care of pregnant women with red blood cell (RBC) alloimmunization. This includes
  monitoring for, and management of fetal anemia caused by maternal red cell alloantibodies,
  but also considerations for transfusion support for the woman in the event of ...
disable_comments: true
---
Hemolytic disease of the fetus and newborn (HDFN) remains an important cause of perinatal morbidity and mortality. HDFN is caused by maternal alloimmunization to red blood cell (RBC) antigens. This article describes and highlights issues in the care of pregnant women with red blood cell (RBC) alloimmunization. This includes monitoring for, and management of fetal anemia caused by maternal red cell alloantibodies, but also considerations for transfusion support for the woman in the event of ...